{"id":"oral-contraceptives","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Nausea"},{"rate":"10-20","effect":"Headache"},{"rate":"10-20","effect":"Breast tenderness"},{"rate":"10-15","effect":"Breakthrough bleeding"},{"rate":"5-10","effect":"Mood changes"},{"rate":"0.3-0.4","effect":"Venous thromboembolism"},{"rate":"5","effect":"Hypertension"},{"rate":"5-10","effect":"Weight gain"}]},"_chembl":{"chemblId":"CHEMBL2108778","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Oral contraceptives contain synthetic estrogen and/or progestin that inhibit the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland, preventing ovulation. They also thicken cervical mucus and alter the endometrium to create a hostile environment for sperm and implantation. The combination of these mechanisms provides contraceptive efficacy of >99% with perfect use.","oneSentence":"Oral contraceptives prevent pregnancy by suppressing ovulation through hormonal inhibition of the hypothalamic-pituitary-gonadal axis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:41:51.758Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception / prevention of pregnancy"},{"name":"Menstrual cycle regulation"},{"name":"Treatment of acne"},{"name":"Endometriosis management"},{"name":"Polycystic ovary syndrome (PCOS) symptom management"}]},"trialDetails":[{"nctId":"NCT00587886","phase":"","title":"Estrogen, Diet, Genetics and Endometrial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2001-09-25","conditions":"Cancer, Endometrial Cancer, Ovarian Cancer","enrollment":1315},{"nctId":"NCT07127458","phase":"NA","title":"Anxiety and Depression in Adolescent PCOS","status":"COMPLETED","sponsor":"Ege University","startDate":"2025-08-17","conditions":"PCOS (Polycystic Ovary Syndrome)","enrollment":42},{"nctId":"NCT07490964","phase":"","title":"Polycystic Ovary Syndrome in Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","startDate":"2026-04-01","conditions":"Type 1 Diabetes Mellitus, Polycystic Ovary Syndrome (PCOS)","enrollment":60},{"nctId":"NCT06991257","phase":"PHASE2","title":"A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-06-19","conditions":"Heart Failure","enrollment":620},{"nctId":"NCT06397612","phase":"NA","title":"Efficacy of Low-dose Percutaneous Electrical Stimulation in Patients With Erectile Dysfunction.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Camilo Jose Cela University","startDate":"2023-12-01","conditions":"Pudendal Nerve Injury, Erectile Dysfunction, Electric Stimulation","enrollment":24},{"nctId":"NCT07235774","phase":"PHASE1","title":"A Drug-drug Interaction Study of Vorasidenib and a Combined Oral Contraceptive in Healthy Female Participants","status":"RECRUITING","sponsor":"Institut de Recherches Internationales Servier (I.R.I.S.)","startDate":"2025-11-05","conditions":"Healthy Adult Female Participants","enrollment":28},{"nctId":"NCT06513104","phase":"PHASE1","title":"A Research Study Looking Into the Effect of NNC0519-0130 on Blood Levels of a Birth Control Pill and Emptying of the Stomach in Women After Menopause","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2024-07-18","conditions":"Diabetes Mellitus, Type 2","enrollment":47},{"nctId":"NCT04451746","phase":"NA","title":"The Influence of Combined Oral Contraception on the DEvelopment and progRession of Chronic venoUs diSeases","status":"COMPLETED","sponsor":"Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia","startDate":"2020-06-24","conditions":"Chronic Venous Diseases","enrollment":116},{"nctId":"NCT07013643","phase":"PHASE1","title":"A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-06-04","conditions":"Healthy Participants","enrollment":75},{"nctId":"NCT07074327","phase":"PHASE1","title":"Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2025-07-11","conditions":"Autosomal Dominant Polycystic Kidney Disease (ADPKD)","enrollment":74},{"nctId":"NCT07225660","phase":"NA","title":"Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)","status":"RECRUITING","sponsor":"Shady Grove Fertility Reproductive Science Center","startDate":"2026-02-25","conditions":"Fertility Preservation","enrollment":394},{"nctId":"NCT03905941","phase":"EARLY_PHASE1","title":"Relative Desirability of Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age","status":"WITHDRAWN","sponsor":"University of Virginia","startDate":"2021-08-23","conditions":"Polycystic Ovary Syndrome","enrollment":""},{"nctId":"NCT07229209","phase":"NA","title":"Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding","status":"COMPLETED","sponsor":"Benha University","startDate":"2025-02-05","conditions":"Abnormal Uterine Bleeding, Cesarean Section Complications, Uterine Scar","enrollment":166},{"nctId":"NCT02283112","phase":"","title":"Validation of Drug Assays in Various Biological Matrices","status":"RECRUITING","sponsor":"University of Liverpool","startDate":"2014-10","conditions":"Infection","enrollment":100},{"nctId":"NCT07419776","phase":"","title":"The Effect Of Polycystic Ovarian Syndrome Treatment On Ocular Surface.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-06-24","conditions":"Poly Cystic Ovary Syndrome","enrollment":90},{"nctId":"NCT07288190","phase":"PHASE2","title":"Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR","status":"NOT_YET_RECRUITING","sponsor":"HIV Prevention Trials Network","startDate":"2026-05-15","conditions":"Pregnancy, HIV Infections","enrollment":300},{"nctId":"NCT06852365","phase":"PHASE2","title":"Combined Oral Contraceptive Pill and Resistance Starch","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-06-10","conditions":"Metabolic Syndrome, Polycystic Ovary Syndrome","enrollment":100},{"nctId":"NCT07384637","phase":"NA","title":"Effects of Progressive Relaxation Exercises and Planned Training After Cesarean Section on Pain, Anxiety and Comfort","status":"COMPLETED","sponsor":"Cumhuriyet University","startDate":"2023-01-01","conditions":"Relaxation Exercises and Training After Cesarean Section","enrollment":129},{"nctId":"NCT01318005","phase":"NA","title":"Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2011-02-14","conditions":"Oral Contraceptive","enrollment":82},{"nctId":"NCT07414784","phase":"PHASE1","title":"A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives","status":"RECRUITING","sponsor":"AbbVie","startDate":"2026-02-11","conditions":"Healthy Volunteer","enrollment":20},{"nctId":"NCT03947684","phase":"","title":"Exploring the Modulatory Role of Sex Hormones Along the Neuromechanical Axis in Females","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2019-04-12","conditions":"Role of Sex Hormones Along the Neuromechanical Axis","enrollment":102},{"nctId":"NCT07388511","phase":"PHASE1","title":"A Study of Elenestinib in Healthy Adult Female Participants","status":"RECRUITING","sponsor":"Blueprint Medicines Corporation","startDate":"2026-02-03","conditions":"Healthy Participants","enrollment":20},{"nctId":"NCT05332639","phase":"NA","title":"Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-10-03","conditions":"Inflammatory Bowel Diseases, Crohn Disease, Crohn Colitis","enrollment":80},{"nctId":"NCT07346690","phase":"PHASE1","title":"A Study Testing the Effects of Different THC Doses on Psychological and Biological Function","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2026-02-01","conditions":"Evaluate PK Profile, Evaluate PD Profile, Healthy Adults","enrollment":24},{"nctId":"NCT07340190","phase":"PHASE1","title":"A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies","status":"NOT_YET_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-05-29","conditions":"Advanced Malignancies","enrollment":24},{"nctId":"NCT07010146","phase":"PHASE2","title":"Role of Estrogen on Skeletal Outcomes in FHA","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2025-07-01","conditions":"Bone Strength, Bone Density, FHA (Functional Hypothalamic Amenorrhea)","enrollment":150},{"nctId":"NCT04756037","phase":"PHASE3","title":"Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sumitomo Pharma Switzerland GmbH","startDate":"2021-03-18","conditions":"Contraception","enrollment":1020},{"nctId":"NCT03106454","phase":"PHASE3","title":"Ovulation Incidence in Oral Contraceptive Users","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2014-08","conditions":"Contraception, Ovulation","enrollment":58},{"nctId":"NCT07242131","phase":"NA","title":"Efficacy of Oral Contraceptive, Progesterone, and Inositol on Menstrual Regulation in PCOS","status":"RECRUITING","sponsor":"Ege University","startDate":"2025-12-01","conditions":"Polycystic Ovary Syndrome (PCOS)","enrollment":150},{"nctId":"NCT04222504","phase":"NA","title":"Community-based Venues for Delivery of Healthcare Services: Proof of Concept Pilot","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-02-08","conditions":"Pre-Exposure Prophylaxis, STI, Contraceptive Usage","enrollment":500},{"nctId":"NCT03043924","phase":"NA","title":"Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS)","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2017-09-26","conditions":"Polycystic Ovary Syndrome","enrollment":52},{"nctId":"NCT07190430","phase":"PHASE1","title":"A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2025-10-03","conditions":"Atopic Dermatitis","enrollment":16},{"nctId":"NCT07272889","phase":"PHASE1","title":"Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)","status":"NOT_YET_RECRUITING","sponsor":"Atea Pharmaceuticals, Inc.","startDate":"2025-12","conditions":"Healthy Volunteer Study","enrollment":24},{"nctId":"NCT05890924","phase":"","title":"Intimate Partner Violence as a Risk Factor for Venous Thromboembolism in Women","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2023-01-01","conditions":"Venous Thrombosis","enrollment":997},{"nctId":"NCT07258576","phase":"NA","title":"Menstrual Cycle vs. Oral Contraceptives: Effects on Muscle Protein Metabolism After Resistance Exercise","status":"RECRUITING","sponsor":"University of Toronto","startDate":"2025-07-20","conditions":"Female Sex Hormones, Menstrual Cycle, Oral Contraceptives","enrollment":20},{"nctId":"NCT00042289","phase":"","title":"Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2003-06-09","conditions":"HIV Infections","enrollment":1578},{"nctId":"NCT05264506","phase":"PHASE3","title":"Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2022-02-17","conditions":"Contraception","enrollment":3055},{"nctId":"NCT03296098","phase":"PHASE2","title":"Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive","status":"WITHDRAWN","sponsor":"Premier Research","startDate":"2020-12","conditions":"Contraception, Healthy Female","enrollment":""},{"nctId":"NCT04333576","phase":"PHASE3","title":"Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2020-08-10","conditions":"Endometriosis","enrollment":800},{"nctId":"NCT06889454","phase":"","title":"Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS","status":"RECRUITING","sponsor":"Attikon Hospital","startDate":"2024-02-01","conditions":"PCOS, Hyperinsulinism, Hyperandrogenism","enrollment":120},{"nctId":"NCT07215806","phase":"PHASE1","title":"Effect of Evobrutinib on Pharmacokinetics of a Combined Oral Contraceptive","status":"COMPLETED","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2022-08-24","conditions":"Healthy","enrollment":20},{"nctId":"NCT03819140","phase":"PHASE4","title":"Continuous Versus Cyclical OCP Use in PCOS","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2019-04-01","conditions":"Polycystic Ovary Syndrome","enrollment":51},{"nctId":"NCT03229057","phase":"PHASE3","title":"Comparing the Effects of Oral Contraceptive Pills Versus Metformin","status":"COMPLETED","sponsor":"Anuja Dokras","startDate":"2018-01-15","conditions":"PCOS","enrollment":240},{"nctId":"NCT05461573","phase":"PHASE3","title":"Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females","status":"COMPLETED","sponsor":"Insud Pharma","startDate":"2022-08-02","conditions":"Contraception, Change in Bone Mineral Density","enrollment":1542},{"nctId":"NCT07195097","phase":"PHASE1","title":"Sildosin as a Male Contraceptive Non Hormonal","status":"NOT_YET_RECRUITING","sponsor":"Benha University","startDate":"2025-09","conditions":"Contraception Use","enrollment":200},{"nctId":"NCT07169591","phase":"","title":"Postprandial Glucose Handing in Contraceptive and IUD Users","status":"RECRUITING","sponsor":"McMaster University","startDate":"2025-10-01","conditions":"Glucose Homeostasis","enrollment":54},{"nctId":"NCT04255277","phase":"PHASE1","title":"To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men.","status":"COMPLETED","sponsor":"Viatris Innovation GmbH","startDate":"2020-01-31","conditions":"Healthy Subjects","enrollment":97},{"nctId":"NCT06394999","phase":"PHASE3","title":"Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2025-05-02","conditions":"Female Contraception","enrollment":1186},{"nctId":"NCT07161440","phase":"","title":"Steroid Profiles in PCOS and Effect of OCP Treatment","status":"COMPLETED","sponsor":"Istanbul University","startDate":"2021-01-02","conditions":"Polycystic Ovary Syndrome (PCOS)","enrollment":56},{"nctId":"NCT06354257","phase":"PHASE1","title":"A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2024-04-05","conditions":"Tuberculosis","enrollment":20},{"nctId":"NCT06334315","phase":"PHASE4","title":"Oral Contraceptive Pill (OCP) Pharmacogenomics","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-10-29","conditions":"Contraception, Pharmacogenomic Drug Interaction","enrollment":700},{"nctId":"NCT06071442","phase":"PHASE1","title":"Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine","status":"COMPLETED","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2024-01-17","conditions":"Healthy Participants","enrollment":60},{"nctId":"NCT03965923","phase":"PHASE3","title":"Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2020-01-09","conditions":"HIV Infections","enrollment":1104},{"nctId":"NCT05316493","phase":"PHASE2, PHASE3","title":"Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia","status":"RECRUITING","sponsor":"Xiaojun Chen","startDate":"2022-06-13","conditions":"Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity","enrollment":172},{"nctId":"NCT01171131","phase":"","title":"A Pilot Study to Identify Biomarkers Associated With Chronic Traumatic Brain Injury","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2010-04","conditions":"Traumatic Brain Injury","enrollment":96},{"nctId":"NCT07084714","phase":"NA","title":"Moderate Aerobic Exercise for Managing Menstrual Cycle Symptoms","status":"RECRUITING","sponsor":"University of Colorado, Colorado Springs","startDate":"2025-07","conditions":"Premenstrual Syndrome, Menstrual Cycle, Menstrual Distress (Dysmenorrhea)","enrollment":35},{"nctId":"NCT07071389","phase":"NA","title":"Specific Supplementation in Counteracting the Adverse Effects of Oral Contraceptives","status":"WITHDRAWN","sponsor":"Lo.Li.Pharma s.r.l","startDate":"2018-01-08","conditions":"Contraception","enrollment":""},{"nctId":"NCT07061093","phase":"","title":"Prospective Evaluation on the Role Exerted by Hormonal Contraceptives on 24-h Blood Pressure. A Prospective Observational Study","status":"RECRUITING","sponsor":"Ospedale Policlinico San Martino","startDate":"2023-10-10","conditions":"Cardiovascular System Diseases (&Amp; [Cardiac])","enrollment":96},{"nctId":"NCT05188014","phase":"NA","title":"Exercise and the Menstrual Cycle in Type 1 Diabetes","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2022-03-15","conditions":"Type 1 Diabetes","enrollment":15},{"nctId":"NCT06043310","phase":"","title":"Estrogen and Microvascular Function","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2023-10-12","conditions":"Estrogen, Cardiovascular Diseases, Microvasculature","enrollment":45},{"nctId":"NCT07043985","phase":"NA","title":"Effect of Vitamin C on Collagen Production in Comparison to Hereditary Gingival Fibromatosis: Histopathological Study","status":"COMPLETED","sponsor":"Badr University","startDate":"2018-01-03","conditions":"Tissue Modification After Vit c Injection","enrollment":20},{"nctId":"NCT03911271","phase":"PHASE2","title":"Low-dose Atropine for the Prevention of Myopia Progression in Danish Children","status":"COMPLETED","sponsor":"Line Kessel","startDate":"2019-05-30","conditions":"Myopia","enrollment":97},{"nctId":"NCT03309293","phase":"NA","title":"Construction and External Validation of a Predictive Clinico-biological Score of the Risk of Venous Thrombosis in Women Under Combined Oral Contraceptives","status":"COMPLETED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2017-01-18","conditions":"Venous Thromboembolism","enrollment":1454},{"nctId":"NCT04972396","phase":"PHASE1","title":"Pemvidutide (ALT-801) DDI Study in Healthy Volunteers","status":"COMPLETED","sponsor":"Altimmune, Inc.","startDate":"2021-09-15","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":40},{"nctId":"NCT07028242","phase":"","title":"Ultrasound and Histology in AEH and Early EEC Treated Conservatively","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2025-06-11","conditions":"Fertility-Sparing Treatment (FST), Atypical Endometrial Hyperplasia, Early Endometrial Cancer (EEC)","enrollment":50},{"nctId":"NCT05002738","phase":"PHASE4","title":"Desogestrel-containing COCP Pharmacokinetic Validation Study","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2021-09-10","conditions":"Contraception","enrollment":22},{"nctId":"NCT06820307","phase":"PHASE1","title":"Evaluation of the Effect of Suzetrigine (SUZ) on the Pharmacokinetics of Oral Contraceptives in Healthy Female Participants","status":"COMPLETED","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2025-02-25","conditions":"Pain","enrollment":50},{"nctId":"NCT06275048","phase":"NA","title":"The Influence of Oral Contraceptives During Disuse","status":"COMPLETED","sponsor":"University of Central Florida","startDate":"2024-01-26","conditions":"Oral Contraceptives, Rehabilitation, Menstrual Cycle","enrollment":41},{"nctId":"NCT02367846","phase":"PHASE4","title":"Assessing the Impact of Contraceptives on Bone Health Using 41Ca","status":"ACTIVE_NOT_RECRUITING","sponsor":"Penn State University","startDate":"2015-01","conditions":"Other Disorders of Bone Development and Growth","enrollment":6},{"nctId":"NCT05988983","phase":"","title":"The Over The Counter Pill National Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2024-05-01","conditions":"Contraception, Contraception Behavior, Contraceptive Usage","enrollment":1026},{"nctId":"NCT06461039","phase":"PHASE1","title":"A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2024-06-14","conditions":"Obesity","enrollment":43},{"nctId":"NCT06775730","phase":"PHASE1","title":"A Drug-Drug Interaction Study of S-217622 With Combined Oral Contraceptives in Healthy Adult Female Participants","status":"COMPLETED","sponsor":"Shionogi","startDate":"2024-12-30","conditions":"Healthy Adult Female Participants","enrollment":24},{"nctId":"NCT04899778","phase":"PHASE4","title":"Do Oral Contraceptives Protect Against ACL Injuries in Female Athletes","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2021-09-29","conditions":"Ligament Injury","enrollment":73},{"nctId":"NCT03249402","phase":"PHASE1","title":"A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult Participants","status":"COMPLETED","sponsor":"Janssen-Cilag International NV","startDate":"2017-08-14","conditions":"Healthy","enrollment":24},{"nctId":"NCT06162611","phase":"PHASE4","title":"Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo","status":"RECRUITING","sponsor":"Lori Gawron","startDate":"2023-11-06","conditions":"Emergency Contraception","enrollment":790},{"nctId":"NCT05233956","phase":"NA","title":"Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya","status":"RECRUITING","sponsor":"FHI 360","startDate":"2023-10-23","conditions":"Anemia","enrollment":600},{"nctId":"NCT04678817","phase":"","title":"Same Day Oral EC and Implant Initiation","status":"COMPLETED","sponsor":"University of Utah","startDate":"2021-02-17","conditions":"Contraception","enrollment":306},{"nctId":"NCT05044962","phase":"NA","title":"Kuwa Free! - Live Free!","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2021-11-26","conditions":"HIV Infections, Contraception, Drug-drug Interaction","enrollment":700},{"nctId":"NCT04669678","phase":"PHASE4","title":"Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South Africa","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2021-11-17","conditions":"HIV Infections, Contraception, Drug-drug Interaction","enrollment":110},{"nctId":"NCT06793943","phase":"PHASE1","title":"A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults","status":"COMPLETED","sponsor":"Takeda","startDate":"2025-01-23","conditions":"Healthy Volunteers","enrollment":78},{"nctId":"NCT06909695","phase":"","title":"Influences of Long-acting Reversible Contraceptives on Iron Status and Physiological Responses to Extreme Environments in Women","status":"RECRUITING","sponsor":"United States Army Research Institute of Environmental Medicine","startDate":"2024-11-01","conditions":"Contraception, Iron Deficiencies","enrollment":33},{"nctId":"NCT05670353","phase":"PHASE2, PHASE3","title":"Cannabidiol for the Treatment of Pelvic Pain in Endometriosis (DREAMLAND)","status":"TERMINATED","sponsor":"University of Sao Paulo","startDate":"2023-01-03","conditions":"Endometriosis, Pelvic Pain","enrollment":50},{"nctId":"NCT06905496","phase":"PHASE1","title":"Apnea of Prematurity Results in Respiratory Distress and Cyanosis. Caffeine Citrate Can Treat It.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nishtar Medical University","startDate":"2024-06-03","conditions":"Apnea of Prematurity","enrollment":114},{"nctId":"NCT03120780","phase":"PHASE4","title":"Epidural Fentanyl for 2nd Stage Labor Analgesia","status":"TERMINATED","sponsor":"Ohio State University","startDate":"2017-06-26","conditions":"Labor Pain","enrollment":65},{"nctId":"NCT04576689","phase":"PHASE2","title":"Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - a Sustained, Low Dose Dexamethasone Therapy","status":"COMPLETED","sponsor":"Ripple Therapeutics Pty Ltd","startDate":"2020-10-30","conditions":"Diabetic Macular Oedema, Retinal Vein Occlusion with Macular Oedema","enrollment":60},{"nctId":"NCT06799884","phase":"PHASE1","title":"A Drug-drug Interaction Trial in Healthy Female Participants to Investigate the Effect of Aprocitentan on Combined Hormonal Contraceptives","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2025-01-18","conditions":"Drug Drug Interaction","enrollment":19},{"nctId":"NCT06865508","phase":"NA","title":"Photo Biomodulation Therapy for Alveolar Osteitis Recovery in Oral Contraceptive Users","status":"COMPLETED","sponsor":"Badr University","startDate":"2023-11-01","conditions":"Alveolar Osteitis","enrollment":50},{"nctId":"NCT00746096","phase":"PHASE3","title":"Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea","status":"COMPLETED","sponsor":"Nobelpharma","startDate":"2008-09","conditions":"Dysmenorrhea","enrollment":115},{"nctId":"NCT06847321","phase":"PHASE2","title":"Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease","status":"RECRUITING","sponsor":"Lighthouse Pharmaceuticals, Inc.","startDate":"2025-02-17","conditions":"Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis","enrollment":300},{"nctId":"NCT06763926","phase":"PHASE4","title":"Intranasal Nafarelin For Triggering Oocyte Maturation","status":"NOT_YET_RECRUITING","sponsor":"Fundacion Dexeus","startDate":"2025-03-15","conditions":"Fertility Disorders","enrollment":134},{"nctId":"NCT05056545","phase":"NA","title":"Postpartum Family Planning Program in Rwanda","status":"RECRUITING","sponsor":"Emory University","startDate":"2022-08-01","conditions":"Family Planning","enrollment":26215},{"nctId":"NCT06188026","phase":"PHASE1","title":"A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2023-12-18","conditions":"Healthy Volunteers (Non-alcoholic Steatohepatitis)","enrollment":34},{"nctId":"NCT05357144","phase":"NA","title":"AmbassADDOrs for Health Study","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2022-07-26","conditions":"HIV Infections","enrollment":140},{"nctId":"NCT06802211","phase":"","title":"CBG Normalization After Discontinuation of COC's","status":"NOT_YET_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2025-02","conditions":"Cessation of Combined Oral Contraceptive Use","enrollment":25},{"nctId":"NCT06783192","phase":"PHASE1","title":"A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-08-14","conditions":"Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis","enrollment":14},{"nctId":"NCT05671653","phase":"PHASE1","title":"A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range","status":"TERMINATED","sponsor":"Pfizer","startDate":"2023-01-19","conditions":"Obesity","enrollment":32},{"nctId":"NCT04785131","phase":"NA","title":"Prune Consumption and Bone Health in Young Women Using Hormonal Contraceptives","status":"COMPLETED","sponsor":"San Diego State University","startDate":"2019-11-30","conditions":"Osteoporosis Risk","enrollment":90},{"nctId":"NCT05347667","phase":"NA","title":"Menstrual Cycle Phase and Oral Contraceptive Pill (OCP) Use on Muscle Protein Synthesis","status":"COMPLETED","sponsor":"McMaster University","startDate":"2022-05-01","conditions":"Menstrual Cycle, Resistance Exercise, Muscle Protein Synthesis","enrollment":24},{"nctId":"NCT06750172","phase":"","title":"Simplification of Oral Sodium Loading Test in the Diagnosis of Primary Aldosteronism: 2-day Replacing 3-day Method","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2023-12-15","conditions":"Primary Aldosteronism","enrollment":33},{"nctId":"NCT05061472","phase":"","title":"A 6-month Observational Study on Combined Oral Contraceptives and Body Weight in Pre-Menopausal Women With Overweight or Obesity","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2022-05-23","conditions":"Contraceptive Usage, Overweight or Obesity, Body Weight Changes","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":21009,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"oral contraceptives","genericName":"oral contraceptives","companyName":"FHI 360","companyId":"fhi-360","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Oral contraceptives prevent pregnancy by suppressing ovulation through hormonal inhibition of the hypothalamic-pituitary-gonadal axis. Used for Contraception / prevention of pregnancy, Menstrual cycle regulation, Treatment of acne.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}